Clinical Trials Browser

FED × Liver Neoplasms × Capecitabine × Clear all

NCT00216437 2007-11-12

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Phase 1 Terminated

Gastrointestinal

Liver Neoplasms